Alexandria Real Estate Equities
ARE
#2303
Rank
NZ$14.49 B
Marketcap
NZ$84.24
Share price
0.72%
Change (1 day)
-41.29%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -NZ$1.01 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are NZ$2.76 Billion. In 2025 the company made an earning of -NZ$1.77 Billion a decrease over its 2024 earnings that were of NZ$1.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$1.01 Billion-43.04%
2025 -NZ$1.77 Billion-242.13%
2024 NZ$1.23 B96.11%
2023 NZ$0.63 B-53.56%
2022 NZ$1.36 B-3.96%
2021 NZ$1.41 B-20.26%
2020 NZ$1.77 B72.88%
2019 NZ$1.02 B3.11%
2018 NZ$0.99 B73.54%
2017 NZ$0.57 B464.88%
2016 NZ$0.10 B-77.32%
2015 NZ$0.44 B36.31%
2014 NZ$0.32 B-10.81%
2013 NZ$0.36 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.28 B-1,282.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$59.74 B-5,849.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$18.29 B-1,860.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-NZ$3.48 Billion 234.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$2.06 B-298.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$21.18 B-2,138.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$2.00 B-292.46%๐Ÿ‡บ๐Ÿ‡ธ USA